Novel insights into the cardio-protective effects of FGF21 in lean and obese rat hearts.
<h4>Aims</h4>Fibroblast growth factor 21 (FGF21) is a hepatic metabolic regulator with pleotropic actions. Its plasma concentrations are increased in obesity and diabetes; states associated with an increased incidence of cardiovascular disease. We therefore investigated the direct effect...
Guardado en:
Autores principales: | Vanlata Patel, Raghu Adya, Jing Chen, Manjunath Ramanjaneya, Muhammad F Bari, Sunil K Bhudia, Edward W Hillhouse, Bee K Tan, Harpal S Randeva |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1e31b47f830c4c7d9cea277508f5121a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Epigenetic modulation of Fgf21 in the perinatal mouse liver ameliorates diet-induced obesity in adulthood
por: Xunmei Yuan, et al.
Publicado: (2018) -
Endogenous FGF21-signaling controls paradoxical obesity resistance of UCP1-deficient mice
por: Susanne Keipert, et al.
Publicado: (2020) -
Author Correction: Endogenous FGF21-signaling controls paradoxical obesity resistance of UCP1-deficient mice
por: Susanne Keipert, et al.
Publicado: (2021) -
Advances in Biological Functions and Clinical Studies of FGF21
por: Lin W, et al.
Publicado: (2021) -
FGF21 serum levels are related to insulin resistance, metabolic changes and obesity in Mexican people living with HIV (PLWH).
por: Arguiñe Ivonne Urraza-Robledo, et al.
Publicado: (2021)